Viewing Study NCT05575635


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-06-21 @ 1:28 AM
Study NCT ID: NCT05575635
Status: UNKNOWN
Last Update Posted: 2022-10-12
First Post: 2022-10-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC
Sponsor: Henan Provincial People's Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neoadjuvant View
None peri-operative View